Acute Migraine Treatment Market to Surpass US$ 7.9 Billion by 2031, Driven by Innovation and Rising Migraine Prevalence
The global acute migraine treatment market is witnessing remarkable growth, fueled by increasing awareness of migraine disorders, growing demand for effective therapies, and continuous advancements in pharmaceutical research. According to the latest industry analysis, the market was valued at US$ 2.1 Billion in 2021 and is projected to expand at a robust CAGR of 15.1% from 2022 to 2031,...
0 Comments 0 Shares 2 Views 0 Reviews